Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen Macmillan Insider Profile
4 Followers
Stephen Macmillan, COB, Pres & CEO, Director at Hologic, holds 2.30M shares in Hologic (Ticker: HOLX), holds 1.51K shares in Illumina (Ticker: ILMN), holds 8.00K shares in Boston Scientific (Ticker: BSX).
Stephen Macmillan Hologic (HOLX)COB, Pres & CEO, Director
Hologic (HOLX)
COB, Pres & CEO, Director
Ranked #32,158 out of 98,564 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+41.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Macmillan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stephen Macmillan
Stephen Macmillan's Trading History
Hologic
Apr 23, 2024
COB, Pres & CEO, Director
Uninformative Sell
―
$177.85M
Illumina
Jun 05, 2023
Director
Uninformative Buy
―
$187.56K
Boston Scientific
Oct 05, 2020
Director
Uninformative Buy
―
$551.92K
Stryker
Feb 08, 2012
President & CEO
Informative Buy
234.25K
$44.52M
Texas Instruments
Jan 30, 2012
Former Director
Uninformative Buy
―
$4.63M
Alere Inc
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Stephen Macmillan's performance on stock
You May Also Like
Stephen Macmillan insider profile FAQ
What is the percentage of profitable transactions made by Stephen Macmillan?
The percentage of profitable transactions made by Stephen Macmillan is 100%.
What is the average return per transaction made by Stephen Macmillan?
The average return per transaction made by Stephen Macmillan is 41.10%.
What stocks does Stephen Macmillan hold?
Stephen Macmillan holds: HOLX, ILMN, BSX, SYK, TXN, ~ALR stocks.
What was Stephen Macmillan’s latest transaction?
Stephen Macmillan latest transaction was an Uninformative Sell of ―.
What was Stephen Macmillan's most profitable transaction?
Stephen Macmillan’s most profitable transaction was an Informative Buy of HOLX stock on February 12, 2014. The return on the trade was 41.20%.
What is Stephen Macmillan's role in Hologic?
Stephen Macmillan's role in Hologic is COB, Pres & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.